The Latest Cardiac and Vascular News
BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in […]
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), announced today its financial results for the quarter ended September 30, 2019. Key Financial Highlights: Revenues for the three months ended September 30, 2019 increased 153% to $54,039, as compared to $21,306 […]
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) announced today that it received a standard notification letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated November 14, 2019, stating that, as a result of not having timely filed its Quarterly Report on Form 10-Q […]
VANCOUVER, British Columbia, Nov. 19, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended September 30, 2019. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS). Q1 2020 BUSINESS HIGHLIGHTS […]
SAN CARLOS, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the third quarter 2019 and filed its quarterly report on Form 10-Q for the three and nine months ended […]
WASHINGTON, Nov. 19, 2019 /PRNewswire/ — MCRA, LLC is a leading medical device advisory firm and clinical research organization (CRO) that integrates regulatory, clinical research, reimbursement, compliance and quality assurance in a coordinated manner to assist companies in bringing new technologies and products to the commercial market. We are pleased to announce the expansion […]
Revenue of $7.7 Billion Increased 3.0% Reported and 4.1% Organic GAAP Diluted EPS of $1.01; Non-GAAP Diluted EPS of $1.31 Cash Flow from Operations of $1.9 Billion Grew 61%; Free Cash Flow of $1.6 Billion Grew 66% Company Raises FY20 EPS Guidance DUBLIN, Nov. 19, 2019 (GLOBE NEWSWIRE) — Medtronic plc […]
ENGLEWOOD, Colo., Nov. 14, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has been ranked 18th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte’s 2019 […]
This National-Level Recognition Follows EY’s New Jersey Regional Entrepreneur of The Year® Award Earlier in 2019 and Reflects Amarin’s Tremendous Business Growth While Helping to Improve Patient Healthcare DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced […]
Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.–(BUSINESS WIRE)–iRhythm Technologies, Inc. shares fell sharply after the company filed a Notification of Late Filing with the Securities and Exchange Commission (SEC) for its Quarterly Report and revealed that it has identified errors affecting prior periods. According to iRhythm, these […]
